Publicacións (28) Publicacións de Diego Bellido Guerrero

filter_list Endocrinology

2024

  1. Use of Tirzepatide in Adults with Type 2 Diabetes Mellitus: Scientific Evidence and Practical Aspects

    Diabetes Therapy, Vol. 15, Núm. 7, pp. 1501-1512

2023

  1. Connected Insulin Pens and Caps: An Expert’s Recommendation from the Area of Diabetes of the Spanish Endocrinology and Nutrition Society (SEEN)

    Diabetes Therapy, Vol. 14, Núm. 7, pp. 1077-1091

  2. Efficacy of a Connected Insulin Pen Cap in People With Noncontrolled Type 1 Diabetes: A Multicenter Randomized Clinical Trial

    Diabetes Care, Vol. 46, Núm. 1, pp. 206-208

  3. Evaluación sensorial de un suplemento nutricional oral específico para diabetes con aceite de oliva virgen extra en pacientes en riesgo nutricional y diabetes mellitus tipo 2: ensayo clínico doble ciego, aleatorizado, cruzado y multicéntrico (DIACARE

    Nutricion hospitalaria, Vol. 40, Núm. 4, pp. 686-691

  4. Experience with the ENDMAP project, a training activity for Family Doctors in Endocrinology and Nutrition

    Atencion Primaria Practica, Vol. 5, Núm. 4

  5. Impacto glucémico e insulinémico de un suplemento nutricional oral con AOVE específico para diabetes en pacientes en riesgo nutricional y con diabetes mellitus tipo 2: ensayo clínico, aleatorizado, doble ciego, cruzado y multicéntrico (DIACARE)

    Nutricion hospitalaria, Vol. 40, Núm. 4, pp. 692-700

  6. Physical activity patterns in type 1 diabetes in Spain: The SED1 study

    BMC Sports Science, Medicine and Rehabilitation, Vol. 15, Núm. 1

2021

  1. DAPA-RWE: A retrospective multicenter study comparing dapagliflozin and sitagliptin in patients with Type 2 diabetes treated under routine clinical practice in Spain

    Journal of Comparative Effectiveness Research, Vol. 10, Núm. 10, pp. 815-821

2020

  1. Ketogenic diets as treatment of obesity and type 2 diabetes mellitus

    Reviews in Endocrine and Metabolic Disorders, Vol. 21, Núm. 3, pp. 381-397

2019

  1. Treatment of Type 2 Diabetes by Patient Profile in the Clinical Practice of Endocrinology in Spain: Delphi Study Results from the Think Twice Program

    Diabetes Therapy, Vol. 10, Núm. 5, pp. 1893-1907

2018

  1. Intensification of Basal Insulin Therapy with Lixisenatide in Patients with Type 2 Diabetes in a Real-World Setting: The BASAL-LIXI Study

    Current Therapeutic Research - Clinical and Experimental, Vol. 89, pp. 37-42

2017

  1. Acid–base safety during the course of a very low-calorie-ketogenic diet

    Endocrine, Vol. 58, Núm. 1, pp. 81-90

  2. Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes

    New England Journal of Medicine, Vol. 377, Núm. 13, pp. 1228-1239

  3. Plasma FGF21 levels in obese patients undergoing energy-restricted diets or bariatric surgery: A marker of metabolic stress?

    International Journal of Obesity, Vol. 41, Núm. 10, pp. 1570-1578

  4. Practical Approach to Initiating SGLT2 Inhibitors in Type 2 Diabetes

    Diabetes Therapy, Vol. 8, Núm. 5, pp. 953-962

2016

  1. Efficacy and safety of LixiLan, a titratable fixed-ratio combination of insulin glargine plus lixisenatide in type 2 diabetes inadequately controlled on basal insulin and metformin: The LixiLan-L randomized trial

    Diabetes Care

2012

  1. Dieta proteinada para pacientes con diabetes tipo 2

    Medicina Interna de Mexico, Vol. 28, Núm. 6, pp. 573-578

2010

  1. Standardisation of the waist circumference (WC) for each range of Body Mass Index (BMI) in adult outpatients attended to in Endocrinology and Nutrition Departments

    Nutricion Hospitalaria, Vol. 25, Núm. 2, pp. 262-269

2008

  1. Cardiovascular risk factor management is poorer in diabetic patients with undiagnosed peripheral arterial disease than in those with known coronary heart disease or cerebrovascular disease. Results of a nationwide study in tertiary diabetes centres

    Diabetic Medicine, Vol. 25, Núm. 4, pp. 427-434

  2. Metformina

    Endocrinologia y Nutricion, Vol. 55, Núm. SUPPL. 2, pp. 39-52